Document is current
Any future updates will be listed below
-
Authors
Chen, Briana K. https://orcid.org/0000-0003-1982-1389
Whye, Alicia
Matthews, Louise C.
Moniz, Taylor
Mendez-David, Indira
Gardier, Alain M.
David, Denis J. https://orcid.org/0000-0002-0506-6688
Johns, Stefanie
Weisblum, Eric
Denny, Christine A. https://orcid.org/0000-0002-6926-2020
- License Information
-
More Information
Article History
Received: 14 January 2025
Revised: 20 March 2025
Accepted: 7 April 2025
First Online: 22 April 2025
Competing interests
: BKC, CAD, IM-D, DJD, and AMG are named on provisional and non-provisional patent applications for the prophylactic use of (R,S)-ketamine, 5-HT4R agonists, and other compounds against stress-related psychiatric disorders and Alzheimer’s disease. BKC is currently Special Projects Manager at NPP. SJ is employed by Silo Pharma, and EW is founder and Chief Executive Officer of Silo Pharma. AW, LCM, and TM have no conflicts of interest to disclose.
